Literature DB >> 15320906

Decreased interferon-alpha production and impaired T helper 1 polarization by dendritic cells from patients with chronic hepatitis C.

H Murakami1, S M F Akbar, H Matsui, N Horiike, M Onji.   

Abstract

Patients with chronic hepatitis C (CHC) are unable to prime and maintain vigorous T cell responses that are initiated during the acute phase of hepatitis C virus (HCV) infection. As dendritic cells (DCs) induce and regulate both innate and adaptive immune responses, the aim of this study was to analyse two critical functions of DCs: firstly, production of interferon (IFN)-alpha and, secondly, polarization of T helper 1 lymphocytes. The frequencies of plasmacytoid DC (PDC) and myeloid DC (MDC) were estimated in 63 patients with CHC and 34 normal controls using four-colour flow cytometry. Circulating DCs were isolated from peripheral blood of CHC patients (n = 10) and normal controls (n = 10). These DCs were cultured with herpes simplex virus-1 to evaluate their capacity to produce IFN-alpha. The capacity of DCs to induce polarization of autologous naive CD4(+) T lymphocytes to IFN-gamma-producing effector T lymphocytes was also assessed. The frequencies of PDCs producing intracellular IFN-alpha (P < 0.01) and the levels of IFN-alpha in culture supernatant of PDCs (P < 0.01) were significantly lower in patients with CHC compared to those of normal controls. The numbers of MDC were significantly lower in patients with CHC (8.2 (6.0)/ micro l, median (interquartile range), n = 63) compared to normal control (11.7 (7.8)/ micro l, n = 34) (P < 0.01). Moreover, DCs from patients with CHC induced significantly lower numbers of IFN-gamma-producing effector T lymphocytes compared to that of controls (P < 0.01). This study indicates that the low IFN-alpha-producing capacity and impaired T helper 1 polarization ability of DCs from patients with CHC might be responsible for the typical low anti-HCV immune responses in these patients.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15320906      PMCID: PMC1809147          DOI: 10.1111/j.1365-2249.2004.02550.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  27 in total

Review 1.  Understanding dendritic cell and T-lymphocyte traffic through the analysis of chemokine receptor expression.

Authors:  F Sallusto; A Lanzavecchia
Journal:  Immunol Rev       Date:  2000-10       Impact factor: 12.988

Review 2.  Dendritic cells: specialized and regulated antigen processing machines.

Authors:  I Mellman; R M Steinman
Journal:  Cell       Date:  2001-08-10       Impact factor: 41.582

3.  Immunodominant CD4+ T-cell epitope within nonstructural protein 3 in acute hepatitis C virus infection.

Authors:  H M Diepolder; J T Gerlach; R Zachoval; R M Hoffmann; M C Jung; E A Wierenga; S Scholz; T Santantonio; M Houghton; S Southwood; A Sette; G R Pape
Journal:  J Virol       Date:  1997-08       Impact factor: 5.103

4.  Analysis of a successful immune response against hepatitis C virus.

Authors:  S Cooper; A L Erickson; E J Adams; J Kansopon; A J Weiner; D Y Chien; M Houghton; P Parham; C M Walker
Journal:  Immunity       Date:  1999-04       Impact factor: 31.745

5.  Impaired allostimulatory function of dendritic cells in chronic hepatitis C infection.

Authors:  C Bain; A Fatmi; F Zoulim; J P Zarski; C Trépo; G Inchauspé
Journal:  Gastroenterology       Date:  2001-02       Impact factor: 22.682

6.  Functional heterogeneity among herpes simplex virus-specific human CD4+ T cells.

Authors:  M Yasukawa; A Inatsuki; T Horiuchi; Y Kobayashi
Journal:  J Immunol       Date:  1991-02-15       Impact factor: 5.422

7.  Hepatitis C virus shares amino acid sequence similarity with pestiviruses and flaviviruses as well as members of two plant virus supergroups.

Authors:  R H Miller; R H Purcell
Journal:  Proc Natl Acad Sci U S A       Date:  1990-03       Impact factor: 11.205

8.  Analysis of successful immune responses in persons infected with hepatitis C virus.

Authors:  F Lechner; D K Wong; P R Dunbar; R Chapman; R T Chung; P Dohrenwend; G Robbins; R Phillips; P Klenerman; B D Walker
Journal:  J Exp Med       Date:  2000-05-01       Impact factor: 14.307

9.  Measles virus infects human dendritic cells and blocks their allostimulatory properties for CD4+ T cells.

Authors:  I Grosjean; C Caux; C Bella; I Berger; F Wild; J Banchereau; D Kaiserlian
Journal:  J Exp Med       Date:  1997-09-15       Impact factor: 14.307

10.  Interferon-alpha and interleukin-12 are induced differentially by Toll-like receptor 7 ligands in human blood dendritic cell subsets.

Authors:  Tomoki Ito; Ryuichi Amakawa; Tsuneyasu Kaisho; Hiroaki Hemmi; Kenichirou Tajima; Kazutaka Uehira; Yoshio Ozaki; Hideyuki Tomizawa; Shizuo Akira; Shirou Fukuhara
Journal:  J Exp Med       Date:  2002-06-03       Impact factor: 14.307

View more
  27 in total

1.  Poly(I:C) and lipopolysaccharide innate sensing functions of circulating human myeloid dendritic cells are affected in vivo in hepatitis C virus-infected patients.

Authors:  Ian Gaël Rodrigue-Gervais; Loubna Jouan; Geneviève Beaulé; Dominike Sauvé; Julie Bruneau; Bernard Willems; Rafick-Pierre Sékaly; Daniel Lamarre
Journal:  J Virol       Date:  2007-03-21       Impact factor: 5.103

2.  Association of enhanced activity of indoleamine 2,3-dioxygenase in dendritic cells with the induction of regulatory T cells in chronic hepatitis C infection.

Authors:  Koyo Higashitani; Tatsuya Kanto; Shoko Kuroda; Sachiyo Yoshio; Tokuhiro Matsubara; Naruyasu Kakita; Tsugiko Oze; Masanori Miyazaki; Mitsuru Sakakibara; Naoki Hiramatsu; Eiji Mita; Yasuharu Imai; Akinori Kasahara; Alato Okuno; Osamu Takikawa; Norio Hayashi; Tetsuo Takehara
Journal:  J Gastroenterol       Date:  2012-09-14       Impact factor: 7.527

3.  Dynamics of immature subsets of dendritic cells during antiviral therapy in HLA-A24-positive chronic hepatitis C patients.

Authors:  Masaaki Shiina; Koju Kobayashi; Tomoo Kobayashi; Yasuteru Kondo; Yoshiyuki Ueno; Tooru Shimosegawa
Journal:  J Gastroenterol       Date:  2006-08       Impact factor: 7.527

4.  Shared alterations in NK cell frequency, phenotype, and function in chronic human immunodeficiency virus and hepatitis C virus infections.

Authors:  Ute-Christiane Meier; Rachel E Owen; Elizabeth Taylor; Andrew Worth; Nikolai Naoumov; Christian Willberg; Kwok Tang; Phillipa Newton; Pierre Pellegrino; Ian Williams; Paul Klenerman; Persephone Borrow
Journal:  J Virol       Date:  2005-10       Impact factor: 5.103

5.  A self-adjuvanting lipopeptide-based vaccine candidate for the treatment of hepatitis C virus infection.

Authors:  Brendon Y Chua; Emily M Eriksson; Lorena E Brown; Weiguang Zeng; Eric J Gowans; Joseph Torresi; David C Jackson
Journal:  Vaccine       Date:  2008-04-07       Impact factor: 3.641

6.  Hepatitis C virus modulates human monocyte-derived dendritic cells.

Authors:  E A Eksioglu; J R Bess; H Zhu; Y Xu; H-J Dong; J Elyar; D R Nelson; C Liu
Journal:  J Viral Hepat       Date:  2010-11       Impact factor: 3.728

7.  Decrease and dysfunction of dendritic cells correlate with impaired hepatitis C virus-specific CD4+ T-cell proliferation in patients with hepatitis C virus infection.

Authors:  Silvia Della Bella; Andrea Crosignani; Antonio Riva; Pietro Presicce; Alberto Benetti; Renato Longhi; Mauro Podda; Maria L Villa
Journal:  Immunology       Date:  2007-06       Impact factor: 7.397

Review 8.  Innate immune cell networking in hepatitis C virus infection.

Authors:  Banishree Saha; Gyongyi Szabo
Journal:  J Leukoc Biol       Date:  2014-07-07       Impact factor: 4.962

9.  Monocyte-derived dendritic cell function in chronic hepatitis C is impaired at physiological numbers of dendritic cells.

Authors:  A J MacDonald; A E Semper; N A Libri; W M C Rosenberg
Journal:  Clin Exp Immunol       Date:  2007-03-15       Impact factor: 4.330

10.  A class C CpG toll-like receptor 9 agonist successfully induces robust interferon-alpha production by plasmacytoid dendritic cells from patients chronically infected with hepatitis C.

Authors:  N A Libri; S J Barker; W M C Rosenberg; A E Semper
Journal:  J Viral Hepat       Date:  2009-02-24       Impact factor: 3.728

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.